Target, Home Depot,...
Health Care: Drugs
Biocryst Pharmaceuticals (BCRX: NASDAQ)
$1.71 -0.02 | -1.16%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -39.08M | -56.95M | -33.85M | -13.45M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 1.27M | 24.40M | 3.49M | -21.74M |
| (Increase) Decrease in Inventories | 263.00K | 635.00K | 5.38M | -6.28M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 2.07M | -10.73M | -9.43M | 20.20M |
| (Decrease) Increase In Other Current Liabilities | 2.30M | 1.31M | -219.68K | 376.97K |
| (Increase) Decrease In Other Working Capital | -9.58M | -1.55M | -2.55M | -2.54M |
| Other Non-Cash Items | 4.92M | 8.77M | 6.30M | 5.52M |
| Net Cash From Continuing Operations | -37.40M | -32.25M | -28.55M | -16.22M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -37.40M | -32.25M | -28.55M | -16.22M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -113.00K | -55.00K | -324.76K | -603.69K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 317.00K | 0.00 | 0.00 | -625.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 24.88M | 11.32M | 221.07K | -12.89M |
| Issuance of Debt | 0.00 | 25.69M | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 18.66M | 1.60M | 835.60K | 48.05M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | -61.00K | -5.01K | -155.50K |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -1.70M | -3.48M | 0.00 | 0.00 |
| Net Cash From Financing Activities | 16.96M | 23.76M | 830.59K | 47.90M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 4.45M | 2.82M | -27.50M | 18.78M |
Portfolios with BCRX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Usermo money
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorHot Biotech Stocks Traded b...
- ContributorUnder-$10 Setting Up To Tra...
- Usertech
Latest BCRX Headlines from TheStreet
- 5 Stocks Under $10 Set to Surge 05.02.13 | 02:05 pm
- 5 Health Care Stocks Under $10 to Watch 04.30.13 | 02:04 pm
- Stocks Gain as Alcoa Beats on Profit 04.08.13 | 04:04 pm
- BioCryst Won't Profit From Bird Flu Outbreak in China 04.08.13 | 03:04 pm
- Stock Futures Rise Ahead of Alcoa Earnings 04.08.13 | 07:04 am
- 3 Pharma Stocks Leaping on Unusual Volume 01.10.13 | 02:01 pm
- The Worst Biotech CEO of 2012 Is... 12.07.12 | 09:12 am
- Your Vote Counts: Who Is the Worst Biotech CEO of 2012? 12.04.12 | 08:12 am
- 5 Biotech Stocks Rising on Unusual Volume 11.20.12 | 02:11 pm
- Biotech Stock Mailbag: Amarin, Sarepta 07.27.12 | 06:07 am
Press Releases for BCRX
- BioCryst Announces Initiation Of A Phase 1 Clinical Trial Of BCX4161 For The Treatment Of Hereditary Angioedema - Business Wire 03.25.13 | 06:03 am
- BioCryst Reports Fourth Quarter And Full Year 2012 Financial Results - Business Wire 02.19.13 | 06:02 am
- BioCryst To Announce Fourth Quarter & 2012 Financial Results On February 19, 2013 - Business Wire 02.05.13 | 01:02 pm
- BioCryst To Present At J.P. Morgan Healthcare Conference - Business Wire 01.02.13 | 01:01 pm
- BioCryst Pharmaceuticals Announces Focused Corporate Strategy And Restructuring - Business Wire 12.07.12 | 06:12 am
- BioCryst Pharmaceuticals And Presidio Pharmaceuticals Mutually Terminate Merger Transaction - Business Wire 11.30.12 | 06:11 am
- BioCryst Broad-Spectrum Antiviral BCX4430 Highly Effective Against Yellow Fever In A Preclinical Disease Model - Business Wire 11.12.12 | 06:11 am
- BioCryst Provides Corporate Update And Reports Third Quarter 2012 Financial Results - Business Wire 11.08.12 | 06:11 am
- BioCryst Announces Outcome From The Peramivir Phase 3 Interim Analysis - Business Wire 11.07.12 | 08:11 pm
- BioCryst To Report Third Quarter 2012 Financial Results On November 8, 2012 - Business Wire 11.01.12 | 02:11 pm
Partner Headlines for BCRX
- BioCryst Pharmaceuticals Earnings: Here’s Why the Stock is Rising Now - Wall St. Cheat Sheet 05.07.13 | 10:05 am
- Pre-Market Most Active for Apr 15, 2013 : S, LIFE, CLWR, MTU, C, BAC, NOK, JCP, BBRY, BCRX, QQQ, FB - NASDAQ 04.15.13 | 12:04 pm
- Pre-Market Most Active for Apr 8, 2013 : BAC, BCRX, ARMH, QQQ, WFT, NXST, LUFK, ARCP, GM^B, MT, GNC, NOK - NASDAQ 04.08.13 | 12:04 pm
- Bird flu fears close China poultry markets - Financial Times 04.06.13 | 11:04 am
- Today's Market News To Trade On: 5 Stocks Moving On News - Seeking Alpha 11.09.12 | 09:11 am
- 2 Biotech Companies With Positive Results That May Be Headed In Opposite Directions - Seeking Alpha 11.08.12 | 09:11 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 07.09.12 | 09:07 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 06.27.12 | 09:06 am
- Today's Market News To Trade On: 5 Stocks Making News - Seeking Alpha 03.23.12 | 08:03 am
- UPDATE: Bird Flu Found in the Netherlands - Benzinga 03.19.12 | 01:03 pm
